The maker of Ozempic and Wegovy found fake 1-milligram injections were being distributed through unauthorized sellers.

If you’ve been using GLP-1 injectable medications like semaglutide and tirzepatide, what have you been doing with those used ...

The FDA and the maker of the popular diabetes and weight loss drug Ozempic are warning people not to use ...

Ozempic (semaglutide) is prescribed to treat ... Finally, never share the pen with anyone, even if the needle has been ...

Ozempic (semaglutide) and Wegovy (semaglutide ... You will need to attach a new needle to the pen each time you administer a dose. You will turn the dose selector on the pen to select your ...

Novo Nordisk has struggled to meet the demand for its blockbuster GLP-1 receptor agonists (GLP-1RA) Wegovy and Ozempic (semaglutide ... The company sold its pen needles and blood glucose ...

The FDA and drugmaker Novo Nordisk on Monday warned that counterfeit vials of Ozempic® (semaglutide ... products were found to include counterfeit needles, which means the FDA could not certify ...

Novo Nordisk A/S (NYSE:NVO) said it had become aware of several hundred units of Ozempic (semaglutide) injection 1 mg distributed outside the Novo Nordisk authorized supply chain in the U.S. The ...

The cardiovascular safety of oral semaglutide, a glucagon-like peptide 1 receptor agonist, has been established in persons with type 2 diabetes and high cardiovascular risk. An assessment of the ...